Improving the outcome for children with cancer: Development of targeted new agents. - Wikidata - awgldk - TriplyDB

Improving the outcome for children with cancer: Development of targeted new agents.

Improving the outcome for children with cancer: Development of targeted new agents.

http://www.wikidata.org/entity/Q36238795

about

Advancing a comprehensive cancer care agenda for children and their families: Institute of Medicine Workshop highlights and next steps The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia.The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemia Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog.Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.Dysregulation of BCL-2 family proteins by leukemia fusion genes.Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.When Life Expectancy is Not Short Enough: A Perspective on the National Institute for Health and Care Excellence (NICE) Preliminary Guidance for Dinutuximab.Editorial: US Cancer Statistics of Survival: Achievements, Challenges, and Future Directions.Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors.Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors

P2860

Q26752816-2F7F157A-487F-475F-9C12-5394A365A938 Q33714126-0A44273B-8F30-409E-9CF0-8A96D38166A5 Q36267151-AC9CBDE9-EADF-4038-85A7-6CC0D641CAB9 Q38614896-56FC2B11-5EFC-452E-967A-F52A5E853BF5 Q38659292-810A3F5D-BF83-4B84-B3E8-AB550D718ECF Q38840660-B449C1AD-A001-43A3-8CC2-86FB71C6BFAE Q39440247-1AE6E212-48B5-49DB-8413-FD6772DA680E Q47118215-03C9D908-8A8C-496E-9165-BE8833B1E35E Q47921573-2D9A75AB-CC0C-40D9-AED1-053E1B7439F4 Q47926517-C06F420D-EA0E-4922-BAFC-4ADB5D2EEC87 Q48007338-E7C80136-360A-4DCB-BEF3-229EEE19C739 Q53741649-1F088BCD-4167-4C2C-975D-AF2B1DA28593 Q56892727-66A55871-9F62-446B-B929-ADA3C961A5F1

P2860

Improving the outcome for children with cancer: Development of targeted new agents.

http://www.wikidata.org/entity/Q36238795

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Improving the outcome for children with cancer: Development of targeted new agents.

@ast

Improving the outcome for children with cancer: Development of targeted new agents.

@en

type

label

Improving the outcome for children with cancer: Development of targeted new agents.

@ast

Improving the outcome for children with cancer: Development of targeted new agents.

@en

prefLabel

Improving the outcome for children with cancer: Development of targeted new agents.

@ast

Improving the outcome for children with cancer: Development of targeted new agents.

@en

P1433

Q36238795-739814F6-50AE-45CA-ADB3-CB7B86AB3603

P1476

Q36238795-5B31A30D-FED4-4256-B1D8-4E71A5095A0C

P2093

Q36238795-D5BAA349-EE9F-467A-AAEC-06EC1F246815

P2860

Q36238795-04F09E9A-2DF7-4392-B900-EF0956B435D8

Q36238795-0567AF0D-2A7F-484A-B0EE-DB5D0B00BF75

Q36238795-082A3E54-29C8-4875-A76D-0E901D3C44EB

Q36238795-09C070D1-9412-4396-87AE-5012E126D1AD

Q36238795-0D4BC6E0-FED3-4C61-B4BB-30E931A3BE68

Q36238795-13053EDF-497A-4316-8834-7EA7D845B4E4

Q36238795-13349D33-B343-4DBB-875E-A113355B1192

Q36238795-173B8F1D-3E22-48BD-BDD7-26A46874AA76

Q36238795-2A7C53DE-CC15-45E7-9E22-FBBD91BCA6C2

Q36238795-312A6495-2096-4C73-8211-8491D63CEB5C

P304

Q36238795-1E844F3D-E800-413A-A296-79EB18D2765D

P31

Q36238795-66A0C6DF-6FEF-4B8D-8E6D-7838A758489C

P356

Q36238795-48A6FD61-E98C-4C6A-A31B-96F53E83FCA6

P407

Q36238795-04313B59-D57A-45C6-B7AF-75074C58FF0E

P433

Q36238795-EC71B7F5-AD6B-4ECD-A45B-E7BEA620653C

P478

Q36238795-76A031DF-1E16-4871-91D2-8F2824B7711F

P577

Q36238795-38DAC481-ACEB-44BF-8994-58D088FD4082

P5875

Q36238795-980EAA51-9A77-4089-B1DB-42C9962349FA

P698

Q36238795-EFE46379-8250-494A-ABBD-2818EF7C654F

P932

Q36238795-E13FFBD4-B794-42FB-913F-FEE6774C7E70

P356

P1433

P1476

Improving the outcome for children with cancer: Development of targeted new agents.

@en

P2093

Peter C Adamson

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Chimeric antigen receptor T cells for sustained remissions in leukemia

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups

RESPONSE TO REPEATED PLATELET TRANSFUSION FROM THE SAME DONOR.

Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group

P304

212-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3322/CAAC.21273

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273385741

http://www.w3.org/2001/XMLSchema#string

P698

25754421

http://www.w3.org/2001/XMLSchema#string

P932

4629487

http://www.w3.org/2001/XMLSchema#string